Drug intelligence / Profile preview

ceftriaxone + co-amoxiclav + dicloxacillin

Development stage
Unknown
Lead developer
Roche
Modality
Small Molecules
Administration
Intravenous, Intramuscular, Oral
01

Overview

This is a combination of three antibiotics: ceftriaxone (a third-generation cephalosporin), co-amoxiclav (amoxicillin with clavulanic acid), and dicloxacillin (a penicillin-type antibiotic). While each component has established antimicrobial properties, this specific three-drug combination is not a standard fixed-dose combination product. Ceftriaxone works by preventing bacteria from making cell walls, while amoxicillin-clavulanate (co-amoxiclav) combines a penicillin antibiotic with a beta-lactamase inhibitor to overcome certain resistance mechanisms. Dicloxacillin is a penicillin-type antibiotic that also targets bacterial cell wall synthesis.

02

Targets

PBP (Penicillin-binding protein family)Neuraminidase

Beyond the preview

Go deeper on ceftriaxone + co-amoxiclav + dicloxacillin.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on ceftriaxone + co-amoxiclav + dicloxacillin.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call